A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER. Asian Journal of Medical Research and Health Sciences, [S. l.], v. 4, n. 01, p. 203–208, 2026. DOI: 10.65605/a-jmrhs.2026.v04.i01.pp203-208. Disponível em: https://ajmrhs.com/journal/article/view/42. Acesso em: 28 feb. 2026.